Patents
Intellectual property notice for the Virtualis platform
The Virtualis platform and the Livemed acuity engine — including the Virtualis mobile and web applications — are protected by one or more United States patents listed below, and by additional patent applications pending in the United States and other jurisdictions. This page is provided as virtual patent marking under 35 U.S.C. § 287(a).
U.S. Patent No. 12,694,994 B2
- Title
- Systems, Methods, and Devices for Message Control
- Issued
- July 28, 2026
- Inventors
- Saamer Siddiqi; Marc Anguiano
- Assignee
- Livemed Health Inc.
AI acuity scoring of clinical messages and consults, acuity-ordered message notifications and push alerts, acuity color/indicator presentation, recommendation (next-best-action) generation, and the human-feedback optimization loop.
The listing of a patent above is for notice purposes and does not constitute an admission that any particular product or feature is covered by, or limited to, that patent. Products may be covered by patents in addition to those listed. This notice does not grant any license, express or implied, to any patent or other intellectual property right. © 2026 Livemed Health Inc. All rights reserved.